Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver.
Melissa Morley, PhD
Advertisement
Articles by Melissa Morley, PhD
Advertisement
Latest Updated Articles
Medicare Expenditures in the First Year of Amyotrophic Lateral Sclerosis DiagnosisPublished: October 20th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform
2
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
3
Catchment Areas Shape Diversity and Access in Oncology Trials: Amir Fathi, MD
4
Managed Care Cast News Roundup: February 10, 2026
5